Quality of evidence matters: is it well reported and interpreted in infertility journals? by Glujovsky, Demian et al.
COMMENTARY
Quality of evidence matters: is it well reported and interpreted
in infertility journals?
Demian Glujovsky1,2,3 & Carlos E. Sueldo2,4 & Ariel Bardach1 & María del Pilar Valanzasca5 &
Daniel Comandé1 & Agustín Ciapponi1,4
Received: 13 August 2019 /Accepted: 12 December 2019
# Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract
Purpose To evaluate if the authors of published systematic reviews (SRs) reported the level of quality of evidence (QoE) in the
top 5 impact factor infertility journals and to analyze if they used an appropriate wording to describe it.
Methods This is a cross-sectional study.We searched in PubMed for SRs published in 2017 in the five infertility journals with the
highest impact factor. We analyzed the proportion of SRs published in the top 5 impact factor infertility journals that reported the
SRs’ QoE, and the proportion of those SRs in which authors used consistent wording to describe QoE and magnitude of effect.
Results The QoE was reported in only 21.4% of the 42 included SRs and in less than 10% of the abstracts. Although we did not
find important differences in the report of QoE of those that showed statistically significant differences or not, p value was
associated with the wording chosen by the authors. We found inconsistent reporting of the size the effect estimate in 54.8% (23/
42) and in the level of QoE in 92.9% (39/42). Whereas the effect size was more consistently expressed in studies with statistically
significant findings, QoE was better expressed in those cases in which the p value was over 0.05.
Conclusion We found that in 2017, less than 25% of the authors reported the overall QoE when publishing SRs. Authors focused
more on statistical significance as a binary concept than on methodological limitations like study design, imprecision, indirect-
ness, inconsistency, and publication bias. Authors should make efforts to report the QoE and interpret results accordingly.
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Introduction
Systematic reviews (SRs) aim to critically analyze and inte-
grate all the information from primary research on a specific
topic. Meta-analysis (MA) is the statistical procedure for com-
bining data from multiple studies, identified through SRs, to
obtain a combined effect. The strength of the evidence that
they provide depends mainly on the quality of the primary
studies identified.
Traditionally, the hierarchy of evidence regarding therapy
or prevention issues has been represented as a pyramid, plac-
ing the strongest designs such as randomized controlled trials
(RCTs) and SRs/MAs at the top. More recently, a new
evidence-based medicine pyramid has been proposed, remov-
ing the SRs from the top of the pyramid and using them as
lenses through which other types of studies should be seen [1].
Despite the increasing use and popularity of SRs, it is crucial
to assess the certainty or quality of evidence (QoE) they pro-
vide, since the design of the primary study itself does not
necessarily guarantee a high QoE. The Grading of
Recommendations Assessment, Development and
Evaluations (GRADE) approach is the soundest system for
rating the certainty of a body of evidence in systematic re-
views and other evidence syntheses. Although GRADE
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currently prefers the use of the word “certainty” [2], we used
the word “quality” throughout this paper because it is proba-
bly better known to the target audience of this manuscript.
GRADE offers a transparent and structured process for
assessing the evidence, developing and presenting evidence
summaries, and making recommendations [3]. GRADE pro-
vides explicit criteria for rating the QoE that includes study
design, imprecision (wide confidence interval), inconsistency
(unexplained heterogeneity of results), indirectness (differ-
ences between the target and the actual population, interven-
tion, and outcomes of interest), and publication bias (a sys-
tematic under/overestimation of the underlying effect due to
the selective publication of studies). These factors can down-
grade the QoE. As a distinctive approach, the QoE is rated for
each outcome considering the whole body of evidence, and it
is classified into four levels (high, moderate, low, and very
low) based on the confidence on the SR estimates [3]. The
QoE and the magnitude of relative and absolute effects for
each important outcome are presented together in standard-
ized Summary of Findings tables, including explanations in
support of factors that affect the QoE grading for each
outcome.
Except for the Cochrane reviews, which report QoE as
established in its manual [4], QoE reporting is infrequent in
non-Cochrane systematic reviews. Even less frequent is that
the level of evidence and the magnitude of the effect are
interpreted using an appropriate wording. We have already
described different types of methodological flaws in RCTs
published in top 5 impact factor infertility journals [5], but
we are describing the findings in SRs in the present work. A
common mistake is to confuse “no evidence of an effect”with
“evidence of no effect.”When the confidence intervals are too
wide, crossing the line of “no effect,” claiming that the inter-
vention has “no effect” or that it is “not different” from the
comparative intervention could be false. When the effect esti-
mate for an outcome is beneficial, but confidence interval is
too wide, authors often describe the effect as “promising.”
However, in a similar situation, when the effect estimate is
considered harmful but the confidence interval includes the
possibility of no effect, authors frequently report “no effect”
[6–9]. Another misleading practice is to frame the conclusion
in wishful terms. For example, if a confidence interval is com-
patible with both a true beneficial effect and a true harmful
effect, both possibilities should be mentioned. Quality of the
evidence is very important to understand the extent to which
the results of a research are reliable. However, QoE is rarely
evaluated or elaborated in the discussion section. When QoE
was evaluated and reported, the effect of the p value still
weighs more than the QoE to draw conclusions [10].
Cochrane groups have proposed narrative statements for
drawing conclusions based on the magnitude of the effect
estimate and the certainty of the evidence of the meta-
analyses and provided a good framework for the analysis in
the last Cochrane Handbook version [7, 8, 11]. Although there
is not a unique valid wording, authors shouldmake an effort to
adapt their words to these two important concepts.
The aim of this study was to describe if the authors of SRs
of interventions in the field of infertility assessed and reported
the QoE of primary research in systematic reviews. In addi-
tion, we analyzed if the level of QoE and magnitude of the
effect were consistent with the wording used by the authors in
results and conclusions.
Material and methods
We performed a cross-sectional study. As we did in some of
our previous studies in which quality of research was evalu-
ated [5, 12] by our group, we selected the five journals focused
on human reproduction with the highest impact factors, ac-
cording to the most recent published list that is the 2018
Impact Factor (from the Institute for Scientific Information)
and the H-index (from SciMagO) [13]. They were Human
Reproduction Update (IF 12.878), Human Reproduction (IF
5.506), Fertility and Sterility (IF 5.411), Reproduction
(Cambridge, England; IF 3.125), and Reproductive
Biomedicine Online (IF 2.930). Impact factor measures if sci-
ence journals’ publications are cited, and importance of a
journal could be estimated using this parameter [14]. Impact
factor is used by many authors to rank journals [15]. Firstly,
we performed a search in September 2018 in PubMed, iden-
tifying the potential SRs with meta-analysis (limits, type of
article: meta-analysis) published in the year 2017, the most
recent complete year at the moment when the search was
done. Secondly, we screened the studies by title and abstract
to include only those that were systematic reviews of interven-
tion and where the main subject of study was infertility. We
excluded those studies researching topics like contraception,
menopause, any other study not done in humans, or any study
that was not a systematic review. After that, two reviewers
(DG, AC, PV, AB) randomly selected, extracted, and indepen-
dently assessed each full text for final eligibility.
Discrepancies were resolved by consensus. We considered a
systematic review as per the classification of the Database of
Abstracts of Reviews of Effect (DARE) [16]. Once we re-
trieved the full text of the systematic reviews, we checked if
the authors evaluated QoE and if they used any specific tool.
We analyzed if they classified the published evidence in the
full text and also if they did it in the abstract. When authors did
not evaluate the QoE, we used GRADE [3] to analyze it. We
described how often a tool for QoE was used by the authors
and the level of the QoE published in the selected systematic
reviews. We also analyzed if using a tool for QoE was asso-
ciated with the p value or not, and if the p value was associated
with the level of the evidence or not. Finally, we analyzed if
the authors made any effort to adapt the wording used in the
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abstract to the QoE and the magnitude of the described esti-
mated effect. For this purpose, we compared the wording used
with the wording proposed both by Cochrane and Support
[6–8].
We used Covidence, a web-based software to facilitate
these phases of classification [17]. We conducted a descriptive
analysis of all evaluated articles, and data was analyzed using
STATA version 11.1 (StataCorp). Pearson’s chi-square statis-
tics were used for determining the degree of independence
between categorical variables. All the authors stated having
no conflicts of interest because they do not participate in any
editorial board of reproductive medicine journals.
Results
General description
We screened 178 studies by title and abstract, and we selected
50 studies to be screened by full text. The rest were excluded
due to the methods or the topic. Of those, eight were excluded
because they did not comply with the requisites needed to be
considered systematic review. The QoE of the included SRs
was evaluated by the authors of those publications in only nine
out of the 42 included studies (21.4%). In those in which the
quality was analyzed, most authors used GRADE (77.8%),
while the rest used other tools. However, when reporting re-
sults in the abstract, the level of the QoEwasmentioned in less
than half (4/9; 44.4%) of those SRs in which it was assessed,
meaning that QoE was stated in the abstract in less than 10%
(4/42) of all the included SRs.
We found no important differences between SRs in which
QoE was evaluated and those in which it was not. When we
analyzed the primary outcomes, we found that in 23 studies
(54.8%), the difference between the intervention and its com-
parator was reported as statistically significant. We did not
find important differences in the report of QoE among those
that showed statistically significant differences vs those that
did not (8.7% vs 10.5%, p = 0.84).
QoE was not assessed in 33 of 42 SRs (78.5%, 95%CI
63.1–89.7), and when we analyzed the QoE when authors
did not, we did not find any bias that suggests that authors
decided to analyze the QoE according to the level of evidence
encountered (see Table 1).
Wording used to describe the results
The reported magnitude of the effect was not expressed with
consistent wording in 23 out of 42 (54.8%, 95%CI 38.7–70.1)
SRs, while the level of QoE was not expressed with consistent
wording in 39 out of 42 (92.9%, 95%CI 80.5–98.5) SRs.
Reporting of statistically significant differences in the pri-
mary outcome was associated with the consistency of the
wording used by the authors in the abstract. When we ana-
lyzed the wording used to state the magnitude of the effect, we
found that it was more consistently expressed in those cases
where the difference was statistically significant whereas in
cases where the p value was over 0.05, the magnitude of the
effect was described in fewer instances (65.2% vs 21.1%; p =
0.004). However, when we analyzed the wording used to state
the level of evidence, we found that the level of QoE was
better expressed in those cases in which the difference was
not statistically significant, while in those cases where the p
value was below 0.05, QoE was always poorly described (0%
vs 15.8%; p = 0.048). Table 2 reports the wording used by
authors in those cases in which the magnitude of the effect
was not shown by the wording used in the abstract.
Discussion
In this study, we found that in 2017, in the top 5 impact factor
infertility journals, less than 25% of authors reported the over-
all QoE when publishing systematic reviews, and even less
than one in 10 reported QoE in the abstract. It was not clear if
it was not reported because QoE was not considered impor-
tant, or because they did not know how to apply it or interpret
it. In fact, when QoE was reported, authors did not usually
choose an appropriate wording. We should emphasize that not
only authors missed to evaluate the QoE but also peer-
reviewers missed to note the QoE absence, or consider that
its absence was important. Although the absence of
Table 1 Quality of evidence
(QoE) level reported or not by the
authors
Reported by the authors N = 9 Not reported by the authors* N = 33
High evidence 0% 9.1% (3/33)
Moderate evidence 33.3% (3/9) 33.3% (11/33)
Low evidence 22.2% (2/9) 18.2% (6/33)
Very low evidence 44.4% (4/9) 39.4% (13/33)
Total 100% (9/9) 100% (33/33)
P = NS
*QoE was analyzed by our team
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assessment of QoE was not associated with any specific out-
come result or any specific characteristic found in the system-
atic reviews (which would have meant a bias), it could limit
the interpretation of the reliability of the results.
A second important finding was that authors usually
interpreted the level of the QoE and the description of the
magnitude of the effect very poorly; the wording used by the
authors in results and discussion was more associated with the
p value than with the overall quality of evidence. In other
words, p value was given more weight than the level of the
QoE and the magnitude of effect in the wording used by the
authors.
In those cases in which the association between the inter-
vention and the outcome was statistically significant, the
wording used to describe the magnitude of the effect was
consistent with the magnitude itself. However, authors were
not accurate enough to describe the magnitude in those cases
in which the p value was higher than 0.05. On the contrary,
authors were more accurate to describe the QoE when the
association was not statistically significant. In those cases in
which the p value was low, but the QoE was not good, the
consistency was not good either. In summary, authors were
less accurate to describe the magnitude in those cases in which
the p value was higher than the cutoff point and were less
accurate to describe the QoE when p values were lower.
Recently, hundreds of scientists rose up against the
reporting of statistical significance as a binary concept. The
false belief that only reaching statistical significance indicates
that a result is “real” has led scientists and journal editors to
legitimize those results, and in this way, distort the literature
[9].
A strength of our study is that we used strict criteria to
classify systematic reviews, but if we would have analyzed
all the studies that were labeled as systematic reviews, the
proportion of QoE reporting probably would have been much
lower. On the other hand, as a limitation, we should say that
QoE classification involves subjective judgments and there
could be some inter-reviewers’ variability, even when all the
reviewers are experts in evidence research, and even if they
used GRADE which is probably the most popular and accept-
ed tool for this purpose. In order to address this issue, two
independent reviewers analyzed each of the included studies.
Another weakness of our study is that, although Cochrane and
Support [6–8] suggest some wording to gain consistency, this
wording is not widely accepted or known by all authors and
editorial boards. Therefore, it should not be considered totally
wrong when authors do not use it. Nevertheless, we did not
classify the studies as consistent or not, according to Cochrane
or Support wording proposals, but we analyzed if authors
made any effort to use specific wording to avoid readers to
be misled by inconsistencies, between effect size, statistics,
and quality of evidence. Finally, as we limited our assessment
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infertility journals, we cannot generalize these results as this
sample could not adequately represent the whole body of ev-
idence coming from all the infertility journals.
When looking for some other studies evaluating the impor-
tance of the interpretation of results, we found a study pub-
lished by McGrath et al. that analyzed 112 systematic reviews
and stated that 72% of them contained at least one form of
overinterpretation in the abstract and 69% in the full text [18].
These authors warn about the risk of making erroneous clin-
ical decisions and recommendations when not being accurate
with the interpretation of the results. On the other hand, both
Lumbreras et al. and Ochodo et al. published two papers in
which they found that overinterpretation of clinical applicabil-
ity in molecular diagnostic research is higher in high impact
factor journals, which they discuss as a concerning feature that
should be improved [19, 20].
The present study shows that authors pay more attention to
discuss if the difference encountered was by chance or not,
and less attention to limitations in the study design, impreci-
sion, indirectness, inconsistency among the primary studies,
and publication bias. Even size effect was not considered
when retrieving conclusions. Whenever authors submit a
study for publication, QoE is very important to understand
the extent of the conclusions that we can arrive at. When
analyzing systematic reviews, reviewers can use AMSTAR
2 [21] and PRISMA [22] to evaluate how the review was
undertaken and how it was reported, respectively. However,
authors should present their results, including the overall eval-
uation of QoE coming from primary studies, which help
readers and policy makers to better understand the importance
of the findings published in that systematic review. Besides,
once the evaluation of QoE has been done, authors should
make efforts to interpret those results in the context of that
evaluation. It is important not only to mention the level of
QoE but also to use an appropriate wording to describe the
results in order to avoid a potential misleading interpretation
by the readers. Of course, this is not only a recommendation
for authors, it is also for editorial boards and referees. Both
those who submit the reports and those who review them
should stress the need for analyzing and reporting the QoE
in this type of research, thereby improving the quality of the
publications in infertility journals.
Systematic reviews are considered one of the study designs
that provide the best QoE. But, its QoE depends mainly on the
quality of each included primary study and the result that
every one of them provide. If authors do not make any effort
to analyze QoE, readers could misinterpret the results.
Systematic reviews per se do not guarantee high QoE, as it
depends partially on the included primary studies. In cases
when QoE is low or very low, readers should clearly under-
stand that evidence is uncertain. When authors analyze QoE
but do not use a consistent wording to describe the results and
conclusions, they could be misleading the readers.
Our study highlights an opportunity for improvement. In
the future, in order to optimize the QoE reporting in SRs,
authors could be more consistent when retrieving conclusions.
There are some initiatives to use narrative statements that are
becoming more popular, such as the one described in the
Cochrane Handbook [6]. On the other hand, editorial boards
could have stricter standards for review, including some op-
tions of statements in the instructions for authors.
There are still many unanswered questions: about which is
the best tool to evaluate QoE?Which is the best wording set to
help readers to better interpret the results? How to deal with
confidence intervals that are very close to the non-effect line?
What is considered large effect and small effect? How is the
best way to state minimal important difference (MID) of a
result? These are just some of the important questions that
have to be addressed in future research.
Conclusions
We found that just one in five SRs of interventions in the field
of infertility assessed and reported the QoE of primary re-
search. In addition, we found that less than half of the SRs
used a wording that was consistent with the effect magnitude
and just one in 10 used a wording consistent with the level of
QoE. Finally, when expressing results, authors of SRs paid
more attention to the statistical significance, as a binary con-
cept, rather than to the methodological limitations like study
design, imprecision, indirectness, inconsistency, and publica-
tion bias.
The findings in our study should be important for authors
and editorial boards at infertility journals. A more consistent
wording should help in giving a more accurate message to
readers and policy makers.
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